Clinical trial

Phase IV Study of Qsymia in Obese Patients

NCT05378503

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2021-09-17

PhasePHASE4

Study timeline

Study start (actual)2021-09-17Date precision: day

Registry last updated2024-01-31

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Obesityunresolved

Interventions

Qsymia 3.75Mg-23Mg Extended Release CapsuleDRUG

Qsymia 7.5Mg-46Mg Extended Release CapsuleDRUG

Qsymia 11.25Mg-69Mg Extended Release CapsuleDRUG

Qsymia 15Mg-92Mg Extended Release CapsuleDRUG

PlaceboDRUG

Sponsors & collaborators

Alvogen Korealead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05378503 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.